{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:56:02Z","timestamp":1760144162919,"version":"build-2065373602"},"reference-count":77,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.rmr.2019.07.008","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T08:07:05Z","timestamp":1568275625000},"page":"1047-1056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alt\u00e9ration des r\u00e9ponses vaccinales avec l\u2019\u00e2ge"],"prefix":"10.1016","volume":"36","author":[{"given":"B.","family":"Autran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2019.07.008_bib0390","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000366162","article-title":"Vaccines for elderly","volume":"61","author":"Del Giudice","year":"2015","journal-title":"Gerontology"},{"key":"10.1016\/j.rmr.2019.07.008_bib0395","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","article-title":"Ageing and infection","volume":"2","author":"Gavazzi","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.rmr.2019.07.008_bib0400","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(14)61347-7","article-title":"The burden of disease in older people and implications for health policy and practice","volume":"385","author":"Prince","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2019.07.008_bib0405","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S adults","volume":"373","author":"Jain","year":"2015","journal-title":"NEJM"},{"key":"10.1016\/j.rmr.2019.07.008_bib0410","first-page":"6","article-title":"Relative clinical and cost burden of community-acquired pneumonia hospitalizations in older adults in the united states-a cross-sectional analysis","author":"Olasupo","year":"2018","journal-title":"Vaccines"},{"key":"10.1016\/j.rmr.2019.07.008_bib0415","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2019.07.008_bib0420","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ni.2588","article-title":"Understanding immunosenescence to improve responses to vaccines","volume":"14","author":"Goronzy","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rmr.2019.07.008_bib0425","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.maturitas.2011.01.011","article-title":"Immunosenescence: implications for vaccination programmes in adults","volume":"68","author":"Lang","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.rmr.2019.07.008_bib0430","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.2174\/15680266113136660181","article-title":"Immune senescence and vaccination in the elderly","volume":"13","author":"Lang","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.rmr.2019.07.008_bib0435","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.it.2009.05.002","article-title":"Vaccination in the elderly: an immunological perspective","volume":"30","author":"Chen","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.rmr.2019.07.008_bib0440","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.4049\/jimmunol.0901022","article-title":"Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response","volume":"184","author":"Panda","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.rmr.2019.07.008_bib0445","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fimmu.2013.00171","article-title":"Immunosenescence and novel vaccination strategies for the elderly","volume":"4","author":"Dorrington","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.rmr.2019.07.008_bib0450","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.exger.2010.08.027","article-title":"Telomere\/telomerase dynamics within the human immune system: effect of chronic infection and stress","volume":"46","author":"Effros","year":"2011","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.rmr.2019.07.008_bib0455","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-4933-8-6","article-title":"Decline of influenza specific CD8+T cell repertoire in healthy geriatric donors","volume":"8","author":"Lee","year":"2011","journal-title":"Immun Ageing"},{"key":"10.1016\/j.rmr.2019.07.008_bib0460","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.vaccine.2012.01.015","article-title":"The unmet need in the elderly: how immunosenescence CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines","volume":"30","author":"McElhaney","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0465","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-4933-9-23","article-title":"CMV and immunosenescence: from basics to clinics","volume":"9","author":"Solana","year":"2012","journal-title":"Immun Ageing"},{"key":"10.1016\/j.rmr.2019.07.008_bib0470","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11357-017-9982-x","article-title":"A constant companion: immune recognition and response to cytomegalovirus with aging and implications for immune fitness","volume":"39","author":"Souquette","year":"2017","journal-title":"Geroscience"},{"key":"10.1016\/j.rmr.2019.07.008_bib0475","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1447-0594.2010.00641.x","article-title":"Immune response to influenza vaccine in the elderly: association with nutritional and physical status","volume":"11","author":"Sagawa","year":"2011","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.rmr.2019.07.008_bib0480","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3389\/fimmu.2018.01035","article-title":"Immune response to primary but not to booster vaccination against hepatitis B in older adults","volume":"9","author":"Weinberger","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.rmr.2019.07.008_bib0485","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1016\/j.vaccine.2011.04.077","article-title":"Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults","volume":"29","author":"Yao","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0490","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mad.2006.11.016","article-title":"Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans","volume":"128","author":"Franceschi","year":"2007","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.rmr.2019.07.008_bib0495","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1532-5415.2005.53512.x","article-title":"Comorbidity is a better predictor of impaired immunity than chronological age in older adults","volume":"53","author":"LeeCastle","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.rmr.2019.07.008_bib0500","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2567.2007.02555.x","article-title":"Immunosenescence: emerging challenges for an ageing population","volume":"120","author":"Aw","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.rmr.2019.07.008_bib0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006601","article-title":"Heterogeneity and longevity of antibody memory to viruses and vaccines","author":"Antia","year":"2018","journal-title":"PLosBiol"},{"key":"10.1016\/j.rmr.2019.07.008_bib0510","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.vaccine.2011.12.055","article-title":"Vaccination of adults 65\u00a0years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix\u00ae): results of two randomized trials","volume":"30","author":"Weston","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0515","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1016\/j.vaccine.2006.06.037","article-title":"Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers","volume":"24","author":"Kaml","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0520","doi-asserted-by":"crossref","first-page":"e82967","DOI":"10.1371\/journal.pone.0082967","article-title":"Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons","volume":"8","author":"Weinberger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.rmr.2019.07.008_bib0525","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20032083","article-title":"Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans","volume":"199","author":"Combadiere","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.rmr.2019.07.008_bib0530","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI38506","article-title":"Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector\/memory CD4+lymphocytes in humans","volume":"120","author":"Puissant-Lubrano","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rmr.2019.07.008_bib0535","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.vaccine.2010.12.029","article-title":"Age-related changes in memory and effector T cells responding to influenza A\/H3N2\u00a0and pandemic A\/H1N1\u00a0strains in humans","volume":"29","author":"Zhou","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0540","first-page":"CD004876","article-title":"Vaccines for preventing influenza in the elderly","volume":"2","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2019.07.008_bib0545","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1016\/j.vaccine.2013.09.063","article-title":"Cochrane re-arranged: support for policies to vaccinate elderly people against influenza","volume":"31","author":"Walter","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0550","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/aje\/kwp173","article-title":"Influenza vaccination and mortality: differentiating vaccine effects from bias","volume":"170","author":"Fireman","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.rmr.2019.07.008_bib0555","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.vaccine.2015.01.023","article-title":"Impact of influenza vaccination on mortality in the French elderly population during the 2000\u20132009\u00a0period","volume":"33","author":"Bonmarin","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0560","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.vaccine.2018.04.037","article-title":"Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged\u226565\u00a0years in Japan","volume":"36","author":"Suzuki","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0565","first-page":"CD004876","article-title":"Vaccines for preventing influenza in the elderly","volume":"2","author":"Demicheli","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2019.07.008_bib0570","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1016\/j.vaccine.2018.08.040","article-title":"Strategies to maximize influenza vaccine impact in older adults","volume":"36","author":"Whitaker","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0575","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coph.2018.03.014","article-title":"Adjuvant strategies to improve vaccination of the elderly population","volume":"41","author":"Weinberger","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.rmr.2019.07.008_bib0580","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/21645515.2015.1011562","article-title":"Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: a literature review","volume":"11","author":"Camilloni","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.rmr.2019.07.008_bib0585","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2019.07.008_bib0590","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2015.07.003","article-title":"Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty","volume":"33","author":"DiazGranados","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0595","first-page":"10","article-title":"Glycoconjugate vaccines: principles and mechanisms","author":"Rappuoli","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.rmr.2019.07.008_bib0600","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1128\/IAI.67.11.5979-5984.1999","article-title":"Determination of antibody responses of elderly adults to all 23\u00a0capsular polysaccharides after pneumococcal vaccination","volume":"67","author":"Rubins","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.rmr.2019.07.008_bib0605","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/infdis\/jir750","article-title":"Hyporesponsiveness following booster immunization with bacterial polysaccharides is caused by apoptosis of memory B cells","volume":"205","author":"Brynjolfsson","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.rmr.2019.07.008_bib0610","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/cid\/cis359","article-title":"Pneumococcal conjugate vaccine for adults: a new paradigm","volume":"55","author":"Paradiso","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2019.07.008_bib0615","first-page":"373","article-title":"Vaccin antipneumococcoque polyosidique 23\u00a0valent. Note de synth\u00e8se de l\u2019OMS","volume":"83","author":"WHO","year":"2008","journal-title":"WER"},{"key":"10.1016\/j.rmr.2019.07.008_bib0620","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"1","author":"Moberley","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2019.07.008_bib0625","first-page":"CDO0422","article-title":"Vaccines for preventing pneumococcal infection in adults","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2019.07.008_bib0630","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1503\/cmaj.080734","article-title":"Efficacy of pneumococcal vaccination in adults: a meta-analysis","volume":"180","author":"Huss","year":"2009","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.rmr.2019.07.008_bib0635","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2019.07.008_bib0640","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","article-title":"Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0645","doi-asserted-by":"crossref","first-page":"e0192640","DOI":"10.1371\/journal.pone.0192640","article-title":"Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands","volume":"13","author":"Thorrington","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.rmr.2019.07.008_bib0650","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.vaccine.2014.02.002","article-title":"Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine\u2013na\u00efve adults 60\u201364\u00a0years of age","volume":"32","author":"Greenberg","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0655","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1016\/j.vaccine.2012.04.093","article-title":"Pneumococcal vaccines WHO position paper\u20132012\u2013Recommendations","volume":"30","author":"Publication","year":"2012","journal-title":"Vaccine"},{"unstructured":"Calendrier vaccinal. Disponible sur http:\/\/social-sante.gouv.fr\/IMG\/pdf\/Calendrier_vaccinal_2015.pdf.","key":"10.1016\/j.rmr.2019.07.008_bib0660"},{"key":"10.1016\/j.rmr.2019.07.008_bib0665","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1080\/21645515.2015.1043502","article-title":"Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults","volume":"11","author":"Isturiz","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.rmr.2019.07.008_bib0670","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.vaccine.2013.04.084","article-title":"Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50\u00a0years and older","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0675","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2019.07.008_bib0680","doi-asserted-by":"crossref","first-page":"ofy100","DOI":"10.1093\/ofid\/ofy100","article-title":"Pneumococcal conjugate vaccine safety in elderly adults","volume":"5","author":"Tseng","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.rmr.2019.07.008_bib0685","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","article-title":"Impact of pneumpcoccal conjugate vaccines on nasophryngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects","volume":"32","author":"Davis","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0690","doi-asserted-by":"crossref","DOI":"10.1186\/s12979-016-0057-0","article-title":"Pneumococcal colonization in older adults","author":"Esposito","year":"2016","journal-title":"Immun Ageing"},{"key":"10.1016\/j.rmr.2019.07.008_bib0695","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/jgs.13651","article-title":"Pneumococcal carriage and vaccine coverage in retirement community residents","volume":"63","author":"Becker-Dreps","year":"2015","journal-title":"J Am Geri Soc"},{"key":"10.1016\/j.rmr.2019.07.008_bib0700","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/ciy009","article-title":"The impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) study","volume":"67","author":"van Deursen","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2019.07.008_bib0705","doi-asserted-by":"crossref","first-page":"ofw020","DOI":"10.1093\/ofid\/ofw020","article-title":"Insight into resistance phenotypes of emergent non 13-valent pneumococcal conjugate vaccine type pneumococci isolated from invasive disease after 13-valent pneumococcal conjugate vaccine implementation in France","volume":"3","author":"Janoir","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.rmr.2019.07.008_bib0710","article-title":"Vaccination des personnes immunod\u00e9prim\u00e9es ou aspl\u00e9niques","author":"Haut Conseil de la sant\u00e9 publique","year":"2014","journal-title":"Recommandations actualis\u00e9es"},{"key":"10.1016\/j.rmr.2019.07.008_bib0715","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1016\/j.vaccine.2008.04.089","article-title":"Predicted long-term persistence of pertussis antibodies in adolescents after un adolescent and adult formulation combined tetanus, diphteria, and 5-component acellular pertussis vaccine, based on modeling and 5-year observed data","volume":"26","author":"Bailleux","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0720","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/655825","article-title":"Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults","volume":"51","author":"Mertsola","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2019.07.008_bib0725","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1016\/j.vaccine.2011.06.049","article-title":"Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix) in adults 55\u00a0years of age and over: a sub-analysis of four trials","volume":"29","author":"Van Damme","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0730","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.vaccine.2011.12.055","article-title":"Vaccination of adults 65\u00a0years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix\u00ae): results of two randomized trials","volume":"30","author":"Weston","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2019.07.008_bib0735","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJMe058181","article-title":"Pertussis-a disease and vaccine for all ages","volume":"353","author":"Halperin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2019.07.008_bib0740","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2019.07.008_bib0745","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CVI.00310-07","article-title":"A double-blind, randomized, controlled multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax","volume":"15","author":"Gilderman","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.rmr.2019.07.008_bib0750","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/528696","article-title":"Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine","volume":"197","author":"Levin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.rmr.2019.07.008_bib0755","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4161\/hv.23412","article-title":"Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax\u00ae) in individuals aged\u226570\u00a0years: a randomized study of a single dose vs. two different two-dose schedules","volume":"9","author":"Vesikari","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.rmr.2019.07.008_bib0760","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/jiv480","article-title":"Cellular and humoral responses to a second dose of herpes zoster vaccine administered 10\u00a0years after the first dose among older adults","volume":"213","author":"Levin","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.rmr.2019.07.008_bib0765","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1086\/522159","article-title":"Vaccination against herpes zoster and postherpetic neuralgia","volume":"197","author":"Oxman","year":"2008","journal-title":"J Infe Dis"},{"key":"10.1016\/j.rmr.2019.07.008_bib0770","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842519303110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842519303110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:19:12Z","timestamp":1760105952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842519303110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":77,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0761842519303110"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2019.07.008","relation":{},"ISSN":["0761-8425"],"issn-type":[{"type":"print","value":"0761-8425"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alt\u00e9ration des r\u00e9ponses vaccinales avec l\u2019\u00e2ge","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2019.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}